Neurodegeneration – News and Features

The mitochondrial protein that controls calcium transport could be a promising target for Alzheimer's and heart disease drugs.

Researchers at Johns Hopkins Medicine discovered that mitochondrial proteins Parkin, PINK1, and OMA1 act as guardians of mitochondrial size and function, playing crucial roles in the development of Parkinson’s disease.

The adult brain can generate new neurons that integrate into key motor circuits, helping to repair damaged neural networks in Huntington's disease.

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the future of precision medicine.

New findings on how the gut microbiome influences drug metabolism and effectiveness could open the door to personalized medicines and better treatment outcomes.

A new computational tool can pinpoint cells that promote health or disease, categorizing thousands of cells into biologically distinct groups.

A study found that individuals who received the vaccine were 20% less likely to develop dementia over seven years. The researchers demonstrated a potential causal link between shingles immunization and reduced dementia risk.

New research illustrates how cells with defective mitochondria activate a special recycling system to eliminate damaged genetic material.

A study from Rutgers University presents a new method for tracking polycystin proteins in polycystic kidney disease (PKD). Using C. elegans as a model, researchers employed fluorescent proteins to observe protein movement and interactions.

Researchers at the University of Surrey discovered that Parkinson’s-related alpha-synuclein accumulates in the heart’s nerve clusters, suggesting that Parkinson’s affects heart function, not just brain and movement.